Skip to main content
Caplight Logo









Credo Diagnostics Biomedical

Credo Diagnostics Biomedical

Private
SingaporeHealthcare & Life Scienceshttps://www.credodxbiomed.com/

Last Round

Accelerator

Jul 16, 2020

Company Overview

Credo Diagnostics Biomedical is a medical technology company that develops, manufactures, and commercializes rapid and affordable point-of-care molecular diagnostic platforms for infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

molecular diagnosticspoint of care testingPOC testingrapid diagnosticsreal-time PCRqPCRportable PCRinfectious disease testingdiagnostic instrumentsdiagnostic assaysveterinary diagnosticsSARS-CoV-2 testinginfluenza testingrazor and blade modelCDMOdiagnostic data managementwhite label diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Credo Diagnostics Biomedical Comparables

Compare Credo Diagnostics Biomedical with similar companies based on industry and business-model similarity.

Credo Diagnostics Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantuMDx
87%
Autonomous Medical Devices Incorporated
81%
Alveo Technologies
81%

Credo Diagnostics Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 16, 2020

Credo Diagnostics Biomedical Investors

Notable investors and investment history

Credo Diagnostics Biomedical investors
InvestorRounds
MedTech InnovatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors increased 683% MoM.

  • Nov 10, 2025

    Monthly visitors grew 224% MoM, reaching 1.2K.

Credo Diagnostics Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Credo Diagnostics Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Credo Diagnostics Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range41
Year Founded2011
Last FundingJul 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?